Skip to main content

Table 3 Expression levels of biomarkers CEA (ng/ml), CA125 (U/ml), CYFRA 21-1 (ng/ml), and NY-ESO-1 (MFI) for LC cases and matched controls in the training (n=230) and validation (n=150) data sets

From: Performance of a multiplexed dual analyte immunoassay for the early detection of non-small cell lung cancer

Biomaker Statistic cancer_train cancer_valid control_train control_valid
CA125 N 115.00 75.00 115.00 75.00
  Mean 16.76 42.18 9.55 8.47
  StdDev 18.85 135.95 7.71 7.29
  Min 2.19 3.56 0.00 0.00
  Max 170.10 1181.4 41.77 54.96
CEA N 115.00 75.00 115.00 75.00
  Mean 6.81 9.60 1.35 1.41
  StdDev 13.87 18.01 0.85 1.03
  Min 0.34 0.25 0.04 0.00
  Max 93.37 71.35 6.28 5.96
CYFRA 21-1 N 115.00 75.00 115.00 75.00
  Mean 15.58 4.60 5.93 1.93
  StdDev 55.49 4.34 9.67 1.73
  Min 0.00 0.00 0.00 0.00
  Max 553.85 21.88 89.09 7.17
NY-ESO-1 N 115.00 75.00 115.00 75.00
  Mean 158.17 133.00 49.76 55.68
  StdDev 442.34 290.50 71.12 63.24
  Min 3.37 4.00 3.33 0.00
  Max 3298.3 1890.8 417.70 420.33